Uppsala, Sweden, June 22, 2010 / b3c newswire /– Biotage (STO: BIOT), a leading supplier of tools and technology for medicinal and analytical chemistry, announced the introduction of ISOLUTE SLE+ High-Performance Supported Liquid Extraction sample preparation columns. The announcement occurred during the 58th ASMS Conference on Mass Spectrometry and Allied Topics in Salt Lake City, Utah USA.
ISOLUTE SLE+ columns were developed in response to customer demand for a larger capacity and as a higher performance alternative to existing columns. The ISOLUTE SLE+ is also available in the new Array format, a modular plate design that provides cost savings and flexibility for method development. Advances in our development process and the unique characteristics of this material make it ideal for analytical environments where performance, simplicity and ruggedness are required.
Unlike labor intensive liquid-liquid extraction and complicated solid phase extraction methods, ISOLUTE SLE+ columns use a simple 3-step methodology, simply load, wait 5 minutes and elute. The ISOLUTE SLE+ columns combine clean extracts with rapid work flow and ease of use that ensure reproducibility. They are also suitable for use with sample volumes from 25uL up to 10ml.
Biotage sample preparation products are supported by a wealth of knowledge and experience in method development and trouble shooting. “Our expertise helps guide customers in choosing the right product and most efficient method that best suits their analytical needs”, says Scott Carr, VP of Commercial Operations. “At Biotage we strive to develop innovative scientific solutions that are simple, reliable and deliver accurate results. This new generation of products exemplifies Biotage’s expertise and continued commitment to high quality sample preparation.”
For more information, please email
or visit www.biotage.com.
About Biotage - www.biotage.com
Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. The customers include the world’s top pharma and biotech companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, and has offices in the United States, United Kingdom and Japan. Biotage has 245 employees and had sales of SEK 394,1m in 2009. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange.
For further product information contact:
Analytical Products Manager
IST House, Cardiff CF82 7TS
Tel: +44 1443 811840
For press information contact:
Director of Marketing Communications
10430 Harris Oaks Blvd. Suite C
Charlotte, North Carolina
Tel: +1 704 654 4847
Fax: +1 704 654 4917